GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that the Tech Council of Maryland (TCM) has named GlycoMimetics the winner of its 2012 Life Sciences Company of the Year award.
